Median value of NPAA and VEGF in lung cancer patients were 156.2 no. of branch points/106 (range, 66.4-250.2) and 40.8 pg/106 (range, 15.85–85.9), and significantly higher than that healthy controls (P<0.001 and P = 0.041, respectively; Table 1). This evidence concerns the gene VEGFA and lung carcinoma.